Smith & Nephew plc SN.

LON: SN. | ISIN: GB0009223206   11/10/2024
1.087,00 GBX (-0,55%)
(-0,55%)   11/10/2024
Grafiek Smith & Nephew plc Grafiek Smith & Nephew plc
donderdag 31 oktober 2024, 08:00
Kwartaalcijfers (3de kwartaal)

Smith & Nephew plc in het nieuws

9 oktober 2024 · Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery · Persbericht

18 september 2024 · First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility · Persbericht

30 juli 2024 · Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers · Persbericht

16 juli 2024 · Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System · Persbericht

9 juli 2024 · Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board · Persbericht

26 juni 2024 · Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game · Persbericht

12 juni 2024 · Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System · Persbericht

18 april 2024 · Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention   · Persbericht

4 april 2024 · Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) · Persbericht

25 maart 2024 · Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner · Persbericht

Profiel Smith & Nephew plc

Smith & Nephew plc, ook bekend als Smith+Nephew, is een Brits multinationaal productiebedrijf van medische apparatuur met hoofdkantoor in Watford, Engeland.

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van chirurgische apparatuur

CEO: Roland Diggelmann

Werknemers: 18.581

Aandelen Smith & Nephew plc

Beurswaarde: 10,26 miljard GBP

Effecten: 874,35 miljoen

Winst per aandeel (12 maand):  PLUS

Mijn selecties